VC fund profile · evidence-aware directory data
FirstMark Capital stages, portfolio and investment profile
New York early-stage venture firm founded in 2008 with $2B+ AUM, backing enterprise software, fintech, and consumer internet. Known for community programs including Data Driven NYC and portfolio support beyond capital.
Keep track of FirstMark Capital
Save this profile to your VCT watchlist for a quick return.
Stage-based planning range
$1M–$10M
This is a planning range inferred from stage coverage, not a firm-disclosed check size.
Methodology: Stage bucket inferred from the rounds a fund leads or invests in.
No firm-specific check-size disclosure is recorded.
Investment stages
Leads: Seed, Series A, Series B+
Participates: Pre-Seed, Seed, Series A, Series B+
Sector focus
generalist-tech
Geography
New York, NY
Founded 2008
Fund size / AUM
$2B+
A separate fund-size evidence record is not yet available.
Portfolio in our directory
5
Linked startup profiles
Recent tracked investment
Not recorded
No dated round explicitly links this fund.
Rounds they lead
Rounds they invest
Last verified: Not recorded. Check-size evidence is labeled by basis so planning estimates are not presented as firm disclosures.
Related reading
Recent investments, portfolio developments and our research on this investor.
Portfolio companies we track
Startups in our directory that list FirstMark Capital as an investor (5 total).
- ActionIQ Composable customer data platform — acquired by Uniphore in December 2024.
- Baba Care coordination for patients and families, combining human advocates, clinicians and AI-supported administrative work.
- Crossbeam Partner ecosystem platform for secure account mapping and B2B co-selling.
- Daytona Cloud sandboxes where AI agents run code and software; $60M Series B at a $1B valuation.
- Function Health Membership-based preventive health platform offering comprehensive lab testing and medical intelligence.
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.